Device / Technology News

RSS

HealthPartners Medical Group to provide timely colorectal cancer screening for African American patients

HealthPartners Medical Group today announced that it has launched an initiative aimed at saving lives by providing more timely colorectal cancer screening for African American patients.

22 Jan 2010

Panel discussion on benefits of oral chemotherapy in cancer care

US Oncology, Inc. partnered with the Association of Community Cancer Centers, Association of Oncology Social Work, American Society for Clinical Oncology, Community Oncology Alliance, Oncology Nursing Society and the National Patient Advocate Foundation in hosting a panel discussion on Capitol Hill today to examine the benefits of oral chemotherapy in cancer care, as well as challenges in its prescribing, accessibility and adherence in the current health care system.

22 Jan 2010

Flexpoint Sensor Systems to develop home monitoring system using patented Bend Sensor design

Flexpoint Sensor Systems, Inc., http://www.flexpoint.com, announced that they are currently working under an agreement with a company on the development of a Home Monitoring Presence Detection System using their patented Bend Sensor® design.

22 Jan 2010

Combination of saliva test with ultra high-tech biopsy process may help prevent genetic disorders

Florida's largest fertility clinic announced it is the first in the state to offer promising new tests against birth defects: a coupling of technologies that will allow couples to avoid passing along more than 100 genetic diseases to their newborn.

22 Jan 2010

New sensor could help diagnose and treat a variety of diseases

A tiny new sensor could provide fresh, inexpensive diagnosis and treatment methods for people suffering from a variety of diseases.

22 Jan 2010

Study shows usefulness of handheld devices for teleconsultation and emergency procedures

Handheld devices such as personal digital assistants (PDAs) and the iPod Touch are prevalent among doctors. However a recent study shows that these devices may be particularly useful for emergency radiologists, who in the near future, may be able to use them for teleconsultation and emergency procedures, according to a study published in the February issue of the American Journal of Roentgenology.

22 Jan 2010

Molecular image guided system for diagnosis and treatment of small-cell peripheral lung cancer

Scientists at The Methodist Hospital Research Institute in Houston received a research grant from the Cancer Prevention Research Institute of Texas (CPRIT) today to develop the first molecular image guided system to diagnose and treat small-cell peripheral lung cancer in one sitting.

22 Jan 2010

Acute adverse reactions rare from using gadolinium-based contrast agents during MRI

Acute adverse reactions from gadolinium-based contrast agents used during magnetic resonance imaging (MRI) to help improve the information seen on the images rarely occur, according to a study published in the February issue of the American Journal of Roentgenology.

22 Jan 2010

Combining ultrasound with proteomic analyses of blood early-stage ovarian cancer can be identified

Noninvasive contrast-enhanced ultrasound imaging, combined with proteomic analyses of blood samples may help physicians identify early-stage ovarian cancer and save the lives of many women, according to an article published in the February issue of the American Journal of Roentgenology.

22 Jan 2010

VNSNY receives funding for testing IT strategies to aid elderly cognitive impairment patients

The Visiting Nurse Service of New York (VNSNY) Center for Home Health Care Policy & Research, the only research center focused on studying home health care in the U.S., has received funding from The Center for Technology and Aging to test state-of-the art information technology (IT) strategies designed to help elderly patients with cognitive impairment and their caregivers safely manage multiple medications.

21 Jan 2010

FDA approves continuous-flow heart-assist device pioneered at Texas Heart Institute at SLEH

The federal Food and Drug Administration today approved a continuous-flow heart-assist device pioneered at the Texas Heart Institute (THI) at St. Luke’s Episcopal Hospital (SLEH) for use as a permanent treatment for advanced heart failure.

21 Jan 2010

Celerus Diagnostics demonstrates Rapid ISH on its Wave RPD System

Through collaborative efforts with multiple industry partners, Celerus Diagnostics has successfully demonstrated Rapid ISH™ (in-situ hybridization) on its forthcoming Wave RPD System.

21 Jan 2010

BMEYE ccNexfin and Masimo Rainbow SET Pulse CO-Oximetry technology receive CE Mark certification

BMEYE B.V., the innovators of combined noninvasive, beat-to-beat blood pressure and cardiac output monitoring, and Masimo, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low-Perfusion pulse oximetry, jointly announce today CE Mark certification and the European launch of the BMEYE ccNexfin—the first noninvasive cardiovascular monitor with Masimo Rainbow SET Pulse CO-Oximetry technology

21 Jan 2010

Data demonstrates overall radiation with digital mammography is less than film mammography

Data from one of the largest mammography trials in history demonstrates that overall the radiation dose associated with digital mammography is significantly lower (averaging 22 percent lower) than that of conventional film mammography and that the reduction could be greater in women with larger and denser breasts, according to a study published in the February issue of the American Journal of Roentgenology.

21 Jan 2010

World’s first Cs-131 implant for colorectal cancer performed at Weill Cornell Medical Center

IsoRay, Inc., announced today that on October 10, 2009, Dr. Bhupesh Parashar, Dr. A Gabriella Wernicke and Dr. KS Clifford Chao from the Department of Radiation Oncology, and Dr. Jeffery Milsom from the Department of Gastrointestinal Surgery, at Weill Cornell Medical Center performed the world’s first Cesium-131(Cs-131) implant for the treatment of colorectal cancer.

21 Jan 2010

Depomed receives second $500,000 milestone payment from Covidien

Depomed, Inc. announced today that it has received a second $500,000 milestone payment under its worldwide license agreement with Covidien focusing on the exclusive development of four acetaminophen/opioid analgesic combination products utilizing Depomed’s Acuform® gastric retentive drug delivery technology. The most recent payment from Covidien, which was received in December 2009, relates to the development of a formulation for the second product candidate under the collaboration.

21 Jan 2010

ResCare chooses GuardianEdge to assist in HIPAA compliance

GuardianEdge, the leader in endpoint data protection, today announced that ResCare, one of the nation's leading providers of services to people with disabilities and the elderly, has selected GuardianEdge to secure the company's more than 6,000 endpoint devices and to assist in Health Insurance Portability and Accountability Act (HIPAA) compliance. To ensure that sensitive patient data is secure, ResCare has deployed GuardianEdge Hard Disk Encryption, GuardianEdge Removable Storage Encryption and GuardianEdge Device Control.

21 Jan 2010

Phase Forward releases Empirica Signal version 7.2 signal detection and management software

Phase Forward, a leading provider of data solutions for clinical trials and drug safety, today announced the availability of version 7.2 of its Empirica™ Signal product, a significant new release of the company’s flagship signal detection and management software. The Empirica Signal solution is a state-of-the-art data mining and knowledge management tool and a cornerstone component of Phase Forward’s Empirica Suite of pharmacovigilance and risk management products.

21 Jan 2010

Rules for patient data security remain widely unenforced

"As the federal government prepares to spend up to $27 billion in stimulus funds to promote electronic medical records, a health technology industry survey suggests that a number of hospitals, health clinics, and insurance firms are violating federal security rules on patient data and putting sensitive health information at risk," The Center for Public Integrity reports.

21 Jan 2010

Genomic Health announces global commercial availability of its Oncotype DX colon cancer test

Genomic Health, Inc. today announced worldwide commercial availability of its Oncotype DX® colon cancer test, the first multigene expression test developed for the assessment of risk of recurrence in patients with stage II disease. The 12-gene advanced diagnostic test is clinically validated to predict individual recurrence risk in stage II colon cancer patients following surgery, as reported at the 2009 American Society of Clinical Oncology (ASCO) meeting.

21 Jan 2010

Device / Technology News

HealthPartners Medical Group to provide timely colorectal cancer screening for African American patients

Panel discussion on benefits of oral chemotherapy in cancer care

Flexpoint Sensor Systems to develop home monitoring system using patented Bend Sensor design

Combination of saliva test with ultra high-tech biopsy process may help prevent genetic disorders

New sensor could help diagnose and treat a variety of diseases

Study shows usefulness of handheld devices for teleconsultation and emergency procedures

Molecular image guided system for diagnosis and treatment of small-cell peripheral lung cancer

Acute adverse reactions rare from using gadolinium-based contrast agents during MRI

Combining ultrasound with proteomic analyses of blood early-stage ovarian cancer can be identified

VNSNY receives funding for testing IT strategies to aid elderly cognitive impairment patients

FDA approves continuous-flow heart-assist device pioneered at Texas Heart Institute at SLEH

Celerus Diagnostics demonstrates Rapid ISH on its Wave RPD System

BMEYE ccNexfin and Masimo Rainbow SET Pulse CO-Oximetry technology receive CE Mark certification

Data demonstrates overall radiation with digital mammography is less than film mammography

World’s first Cs-131 implant for colorectal cancer performed at Weill Cornell Medical Center

Depomed receives second $500,000 milestone payment from Covidien

ResCare chooses GuardianEdge to assist in HIPAA compliance

Phase Forward releases Empirica Signal version 7.2 signal detection and management software

Rules for patient data security remain widely unenforced

Genomic Health announces global commercial availability of its Oncotype DX colon cancer test

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News